Zymeworks Inc.
ZYME- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001937653
No open-market purchases or sales by Zymeworks Inc. insiders were filed in the last 90 days; 202 institutions reported holding it in 13F filings for Q2 2026, worth $1.79B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Zymeworks Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- +21 vs. Q4 2022
- Shares held
- 56.7M
- −535.1K (−0.9%) vs. Q4 2022
- Total value
- $512.6M
- +$62.8M (+14.0%) vs. Q4 2022
- New holders
- 40
- 36 more added
- Sold out
- 19
- 27 more reduced
1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ZYME on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 202 | $1.79B |
| Q1 2026 | 212 | $1.76B |
| Q4 2025 | 210 | $1.88B |
| Q3 2025 | 184 | $1.26B |
| Q2 2025 | 182 | $949.0M |
| Q1 2025 | 186 | $840.9M |
| Q4 2024 | 174 | $973.2M |
| Q3 2024 | 163 | $834.7M |
| Q2 2024 | 164 | $580.6M |
| Q1 2024 | 171 | $713.0M |
| Q4 2023 | 157 | $674.0M |
| Q3 2023 | 140 | $395.5M |
| Q2 2023 | 137 | $547.9M |
| Q1 2023 | 116 | $512.6M |
| Q4 2022 | 96 | $449.9M |
| Q3 2022 | 91 | $293.7M |
| Q2 2022 | 114 | $253.3M |
| Q1 2022 | 120 | $327.3M |
| Q4 2021 | 114 | $693.9M |
| Q3 2021 | 123 | $1.07B |
| Q2 2021 | 109 | $1.20B |
| Q1 2021 | 125 | $1.12B |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Zymeworks Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 610,000 | $5.51M | 0.40% | 00.0% | Unchanged |
| Millennium Management LLC | 649,183 | $5.87M | 0.01% | +533,661+462.0% | Added |
| Granahan Investment Management Inc | 650,389 | $5.88M | 0.18% | −88,059−11.9% | Reduced |
| BlackRock Inc. | 751,573 | $6.79M | 0.00% | +75,166+11.1% | Added |
| Tang Capital Management LLC | 1,100,000 | $9.94M | 1.48% | +700,000+175.0% | Added |
| Samsara BioCapital, LLC | 1,620,687 | $14.7M | 3.03% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 2,000,000 | $18.1M | 0.11% | +500,000+33.3% | Added |
| Vanguard Group Inc | 2,040,149 | $18.4M | 0.00% | −496,246−19.6% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 2,306,472 | $20.9M | 0.07% | +14,665+0.6% | Added |
| Credit Suisse AG | 2,485,285 | $22.5M | 0.02% | +46,190+1.9% | Added |
| Rubric Capital Management LP | 2,854,732 | $25.8M | 1.03% | −163,485−5.4% | Reduced |
| Perceptive Advisors LLC | 3,378,498 | $30.5M | 0.90% | −1,132,777−25.1% | Reduced |
| Morgan Stanley | 5,563,301 | $50.3M | 0.01% | −10,079−0.2% | Reduced |
| BVF Inc | 5,870,000 | $53.1M | 1.94% | 00.0% | Unchanged |
| Redmile Group, LLC | 6,067,918 | $54.9M | 2.38% | −108,000−1.7% | Reduced |
| EcoR1 Capital, LLC | 10,087,473 | $91.2M | 2.94% | +2,518,900+33.3% | Added |
| Baker Bros. Advisors LP | 0 | $0 | 0.00% | −1,708,472−100.0% | Sold out |
| Brookfield Asset Management Inc. | 0 | $0 | 0.00% | −741,186−100.0% | Sold out |
| Sessa Capital IM, L.P. | 0 | $0 | 0.00% | −740,878−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −600,403−100.0% | Sold out |
| Artal Group S.A. | 0 | $0 | 0.00% | −450,000−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −369,187−100.0% | Sold out |
| Sectoral Asset Management Inc | 0 | $0 | 0.00% | −192,124−100.0% | Sold out |
| Ci Investments Inc. | 0 | $0 | 0.00% | −147,170−100.0% | Sold out |
| Candriam Luxembourg S.C.A. | 0 | $0 | 0.00% | −120,305−100.0% | Sold out |
| Thrivent Financial for Lutherans | 0 | $0 | 0.00% | −117,092−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −52,500−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −51,180−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −27,939−100.0% | Sold out |
| Walleye Trading LLC | 0 | $0 | 0.00% | −24,378−100.0% | Sold out |
| Forefront Wealth Management Inc. | 0 | $0 | 0.00% | −13,400−100.0% | Sold out |
| Alpine Global Management, LLC | 0 | $0 | 0.00% | −13,046−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |